Jump to:
Documenting Consent | Re-consenting or Notifying | Posting Consent Forms | OHRP FAQs |
Consent Discussion Process
The consent process should allow for an exchange of information between the investigator and the subject. Even the best document is no substitute for two-way communication, interaction, and listening.
- For complex or detailed studies, consider sending information and consent document in advance to allow potential participant time to review and think of questions.
- Introduce yourself and take time to ask questions to assess prospective participant’s knowledge, experience, frame of mind, health literacy, motives, etc.
- Actively listen!
- Use plain language. Be specific and concreate in communication.
- Clarify what is and what is not part of the research (e.g., what will occur regardless of their participation such as standard of care procedures).
- Describe foreign or technical concepts.
- Use visual aids, glossary of terms, video or audio, illustrations, models or samples of interventional products.
- Provide foundational education as needed (e.g., what is disease and standard treatment; what is a clinical trial, research purpose you are partnering with them to discover or solve)
- If you are treatment provider, clarify that this is “research” to prevent therapeutic misconception.
- If you are in a position of authority, reiterate that participation is totally voluntary and withdrawal is always an option (e.g., teachers, employers).
- Use teach-back open-ended questions to assess understanding and clarify misperceptions.
- After the study, evaluate your process by asking participant what they wish they would have known.
Documenting the Informed Consent Process
Include the following:
- Statement that “eligibility criteria met” (or completed eligibility checklist attached);
- Date;
- Details of who involved/present;
- Description of process;
- Discussion items;
- Questions & clarifications;
- Any assessment used to document understanding;
- Statement that subject voluntarily consented to participate prior to participating;
- Copy of signed consent given to subject;
- Any other pertinent information (witness, LAR, supplemental materials);
- PI contact information;
- IRB number;
- Protocol title;
- Version of the consent document signed.
Samples (Please note: These may not suit your protocol precisely, however, they may serve as a guide to get you started):
Re-consenting or Notifying Participants
Would you ever need to re-consent a research participant? [D100.0000] [PDF]
Future Research Use
- Primary Research & Future Use [HTML Interactive Tool] – what to do and what to tell participants